Compare Stocks: PFSA, ICCM, INBS, and MBAI

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ICCM IceCure Medical	$1.57 -7.1%	$2.39	$1.55 ▼ $42.00	$5.79M	0.43	119,166 shs	307,427 shs
INBS Intelligent Bio Solutions	$1.66	$2.12	$1.52 ▼ $24.90	$5.51M	4.31	42,785 shs	42,966 shs
MBAI MBody AI	$3.29 +4.1%	$6.89	$3.03 ▼ $27.44	$4.35M	0.66	24,032 shs	12,350 shs
PFSA Profusa	$1.69 -9.6%	$3.94	$1.58 ▼ $3,000.00	$1.13M	0.53	5.23 million shs	362,826 shs

10 Best Stocks to Own in Fall 2026

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ICCM IceCure Medical	-7.10%	-9.25%	-30.53%	-70.71%	-94.67%
INBS Intelligent Bio Solutions	0.00%	-2.35%	-32.79%	-25.89%	-84.04%
MBAI MBody AI	+4.11%	-28.32%	-49.23%	-58.77%	+328,999,900.00%
PFSA Profusa	-9.63%	-22.48%	-36.70%	-81.93%	+168,999,900.00%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ICCM IceCure Medical	$1.57 -7.1%	$2.39	$1.55 ▼ $42.00	$5.79M	0.43	119,166 shs	307,427 shs
INBS Intelligent Bio Solutions	$1.66	$2.12	$1.52 ▼ $24.90	$5.51M	4.31	42,785 shs	42,966 shs
MBAI MBody AI	$3.29 +4.1%	$6.89	$3.03 ▼ $27.44	$4.35M	0.66	24,032 shs	12,350 shs
PFSA Profusa	$1.69 -9.6%	$3.94	$1.58 ▼ $3,000.00	$1.13M	0.53	5.23 million shs	362,826 shs

10 Best Stocks to Own in Fall 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ICCM IceCure Medical	-7.10%	-9.25%	-30.53%	-70.71%	-94.67%
INBS Intelligent Bio Solutions	0.00%	-2.35%	-32.79%	-25.89%	-84.04%
MBAI MBody AI	+4.11%	-28.32%	-49.23%	-58.77%	+328,999,900.00%
PFSA Profusa	-9.63%	-22.48%	-36.70%	-81.93%	+168,999,900.00%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ICCM IceCure Medical	2.20	Hold	$52.50	3,243.95% Upside
INBS Intelligent Bio Solutions	1.50	Reduce	N/A	N/A
MBAI MBody AI	2.00	Hold	$10.00	203.95% Upside
PFSA Profusa	1.00	Sell	N/A	N/A

Current Analyst Ratings Breakdown

Latest PFSA, ICCM, INBS, and MBAI Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/29/2026	MBAI MBody AI	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold
9/28/2026	MBAI MBody AI	Northland Securities Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Outperform	$10.00
8/27/2026	PFSA Profusa	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E) ➝ Sell (E+)
8/14/2026	PFSA Profusa	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (E+) ➝ Sell (E)
8/14/2026	ICCM IceCure Medical	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
7/21/2026	MBAI MBody AI	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/17/2026	ICCM IceCure Medical	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/17/2026	INBS Intelligent Bio Solutions	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)

(Data available from 10/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ICCM IceCure Medical	$3.38M	1.59	N/A	N/A	$3.72 per share	0.42
INBS Intelligent Bio Solutions	$4.22M	1.31	N/A	N/A	$2.21 per share	0.75
MBAI MBody AI	N/A	N/A	$4.16 per share	0.79	$3.30 per share	N/A
PFSA Profusa	N/A	N/A	N/A	N/A	($2,168.90) per share	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ICCM IceCure Medical	-$15.06M	-$8.52	N/A	N/A	N/A	-427.67%	-174.26%	-112.58%	11/18/2026 (Estimated)
INBS Intelligent Bio Solutions	-$12.43M	-$9.02	N/A	N/A	N/A	-294.88%	-175.35%	-91.25%	11/11/2026 (Estimated)
MBAI MBody AI	$4.14M	-$14.07	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PFSA Profusa	-$35.82M	-$5,619.96	N/A	N/A	N/A	N/A	N/A	-1,731.09%	N/A

Latest PFSA, ICCM, INBS, and MBAI Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
8/19/2026	Q4 2026	INBS Intelligent Bio Solutions	-$1.58	-$0.90	+$0.68	-$0.90	$1.22 million	$1.15 million
8/19/2026	Q2 2026	PFSA Profusa	N/A	-$151.80	N/A	-$151.80	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
ICCM IceCure Medical	N/A	N/A	N/A	N/A	N/A
INBS Intelligent Bio Solutions	N/A	N/A	N/A	N/A	N/A
MBAI MBody AI	N/A	N/A	N/A	N/A	N/A
PFSA Profusa	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ICCM IceCure Medical	N/A	2.88	2.44
INBS Intelligent Bio Solutions	N/A	1.44	1.35
MBAI MBody AI	N/A	N/A	N/A
PFSA Profusa	N/A	0.03	0.03

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ICCM IceCure Medical	0.62%
INBS Intelligent Bio Solutions	32.97%
MBAI MBody AI	1.07%
PFSA Profusa	9.81%

Insider Ownership

Company	Insider Ownership
ICCM IceCure Medical	2.44%
INBS Intelligent Bio Solutions	1.27%
MBAI MBody AI	0.48%
PFSA Profusa	15.00%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ICCM IceCure Medical	66	3.43 million	3.34 million	Not Optionable
INBS Intelligent Bio Solutions	10	3.32 million	3.28 million	Not Optionable
MBAI MBody AI	85	1.38 million	1.37 million	N/A
PFSA Profusa	2	606,000	515,000	N/A

PFSA, ICCM, INBS, and MBAI Headlines

Recent News About These Companies

Profusa Announces Significant Progress towards Lumee Oxygen Platform CE Mark with ISO 13485 certification Expected in Early October

September 25, 2026 | marketscreener.comM

Analyzing OraSure Technologies (NASDAQ:OSUR) & Profusa (NASDAQ:PFSA)

September 25, 2026 | americanbankingnews.com

Here’s What Investors Are Watching, Including $20 Price Target Bombshell

September 24, 2026 | markets.businessinsider.com

Profusa ISO 13485 certification decision advances Lumee oxygen platform toward CE mark

September 24, 2026 | msn.com

Micro Cap Profusa Navigates European Regulatory Hurdles to Advance Oxygen Monitoring Tech

September 24, 2026 | benzinga.com

Profusa Advances Lumee Oxygen Platform Toward CE Mark

September 24, 2026 | rttnews.com

Profusa Announces Significant Progress Towards Lumee® Oxygen Platform CE Mark with ISO 13485 Certification Expected in Early October

September 24, 2026 | globenewswire.com

Profusa Receives Nasdaq Confirmation Of Compliance ;Shares Slide

September 15, 2026 | rttnews.com

Profusa clears NASDAQ compliance issues

September 15, 2026 | msn.com

Profusa Regains Nasdaq Compliance, Enters One-Year Monitoring

September 15, 2026 | tipranks.com

Profusa, Inc. Receives Nasdaq Compliance Determination Letter Confirming Bid Price and Equity Rule Compliance

September 15, 2026 | quiverquant.comQ

Profusa, Inc. Receives Nasdaq Compliance Determination

September 15, 2026 | globenewswire.com

Profusa Resolves Nasdaq Compliance Issue

September 1, 2026 | rttnews.com

Profusa regains Nasdaq compliance; shares up

August 31, 2026 | msn.com

Profusa Receives Nasdaq Notice on Publicly Held Shares Requirement, Compliance Confirmed and Review Closed

August 31, 2026 | quiverquant.comQ

Profusa, Inc. Announces Compliance with Nasdaq Publicly Held Shares Requirement

August 31, 2026 | globenewswire.com

Profusa advances G3 Vision Labs acquisition conditions as Q2 net loss widens

August 20, 2026 | msn.com

Profusa Announces Q2 2026 Financial Results and Progress on the Option Agreement Conditions to Close with G3 Vision Labs, a Commercial Stage Diagnostics Company

August 20, 2026 | globenewswire.com

Profusa (NASDAQ:PFSA) Major Shareholder Financial Lp Hrt Sells 42,411 Shares of Stock

August 15, 2026 | insidertrades.com

Profusa delays quarterly SEC filing briefly

August 14, 2026 | tipranks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

PFSA, ICCM, INBS, and MBAI Company Descriptions

IceCure Medical NASDAQ:ICCM

$1.57 -0.12 (-7.10%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$1.63 +0.06 (+4.08%)

As of 10/2/2026 07:57 PM Eastern

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.

Intelligent Bio Solutions NASDAQ:INBS

$1.66 0.00 (0.00%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$1.73 +0.07 (+4.28%)

As of 10/2/2026 07:50 PM Eastern

Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.

MBody AI NASDAQ:MBAI

$3.29 +0.13 (+4.11%)

Closing price 10/2/2026 03:57 PM Eastern

Extended Trading

$3.20 -0.09 (-2.74%)

As of 10/2/2026 07:16 PM Eastern

MBody AI, Inc. (NASDAQ:MBAI) is a technology company focused on applying artificial intelligence to health, wellness and body-composition management. Its business centers on developing digital tools intended to help users better understand and manage aspects of their fitness, nutrition and overall well-being. The company’s products and services are designed to use data-driven insights and personalized recommendations to support individual health and wellness goals. Publicly available information about MBody AI’s specific product portfolio, operating geographies and leadership team is limited. MBody AI is an emerging company, and additional details about its commercial operations and corporate history may become available through future regulatory filings and company disclosures.

Profusa NASDAQ:PFSA

$1.69 -0.18 (-9.63%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$1.78 +0.09 (+5.03%)

As of 10/2/2026 07:59 PM Eastern

NorthView Acquisition Corporation does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to focus its search on businesses that are focused on healthcare sector. The company was incorporated in 2021 and is based in New York, New York. NorthView Acquisition Corporation is a subsidiary of NorthView Sponsor I, LLC.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PFSA, ICCM, INBS, and MBAI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PFSA, ICCM, INBS, and MBAI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PFSA, ICCM, INBS, and MBAI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

PFSA, ICCM, INBS, and MBAI Company Descriptions

IceCure Medical NASDAQ:ICCM

Intelligent Bio Solutions NASDAQ:INBS

MBody AI NASDAQ:MBAI

Profusa NASDAQ:PFSA

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PFSA, ICCM, INBS, and MBAI Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PFSA, ICCM, INBS, and MBAI Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PFSA, ICCM, INBS, and MBAI Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

PFSA, ICCM, INBS, and MBAI Company Descriptions

IceCure Medical NASDAQ:ICCM

Intelligent Bio Solutions NASDAQ:INBS

MBody AI NASDAQ:MBAI

Profusa NASDAQ:PFSA

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools